Event Brief
Moderna begins Phase 1 trial for Bundibugyo Ebola vaccine
Filed: Aug 05, 2026 at 9:10 AM ET
Summary: Moderna vaccinated first volunteers in a Phase 1 trial for a Bundibugyo Ebola mRNA vaccine in Canada.
WHO: Moderna
WHAT: Vaccinated first participants in a Phase 1 trial of an mRNA Bundibugyo Ebola vaccine candidate
WHEN: Aug 05, 2026 at 8:31 AM ET
WHERE: Canada
WHY: To evaluate safety, tolerance, and immune response for the Bundibugyo strain of Ebola virus disease, for which there is currently no vaccine
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
🔍 6 sources analyzed
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →